The largest database of trusted experimental protocols

20 protocols using moflo sorter

1

Enrichment and Characterization of OV6+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were labelled with primary OV6 antibody (mouse IgG1; R&D Systems, Minneapolis), magnetically tethered to rat anti-mouse IgG1 microbeads, and sorted with a Mini-MACS™ Cell Sorter Kit (Miltenyi Biotec, CA). All of the procedures were following the manufacturer’s instructions. The sorted cells were evaluated by flow cytometry analysis. The flow cytometry was performed with MoFlo Sorter (Beckman, Brea, CA) using an APC-conjugated-OV6 antibody (R&D Systems, Minneapolis) and following manufacturer’s instruction.
+ Open protocol
+ Expand
2

Enrichment of MLL^Dim Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate Halo-tagged MLLDim cells, HEK293 cells were transfected with pFENHK-MLL plasmid with Polyethylenimine. 2 days later, the transfected cells were selected with 400 ng/ml G418 for 3 weeks and stained with HaloTag R110Direct ligand (Promega). Cells were then sorted according to the Halo-tag signals with a MoFlo sorter (Beckman Coulter) as MLLNegative, MLLDim, MLLMid, and MLLHigh. The sorted cells were grown in DMEM with 10% FBS and selected with 400 ng/ml G418. 2 weeks later, the cells were resorted according to HaloTag signals. The MLLDim were further sorted two more times.
+ Open protocol
+ Expand
3

Isolation and Sorting of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were prepared from 12-week mice, erythrocytes were removed by incubation in lysis buffer (1:9 v/v 0.17M Tris: 0.16 M ammonium chloride) for 5 min and enriched splenocytes were resuspended in 2% FBS and 1 mM EDTA in Hank’s Balanced Salt Solution. For isolation of tumour lineages, dissected gp130F/F gastric tumours were chopped into ~3–4mm3 pieces and disaggregated non-enzymatically by incubation in dissociation buffer (5% FBS, 1 mM dithiothreitol, 1 mM EDTA in PBS) for 1 h at 37 °C with agitation. Digested tissue pieces were passed through a 70-μm strainer, and the cells were resuspended in 2% FBS and 2 mM EDTA in Hank’s Balanced Salt Solution. Splenocytes and gastric tumour cells were stained with CD11c-APC (1:500), CD8α-APC-Cy7 (1:500), CD45R/B221-FITC (1:500), CD11b-PE (1:500), Gr-1 (Ly6-G/C)-PerCP-Cy5.5 (1:300) (all from BD Biosciences) and NK1.1-brilliant violet 421 (1:300) E-cadherin-PE (1:300) (from BioLegend, San Diego, CA, USA). Cells were sorted (at low pressure with a 100-μm nozzle) on a MoFlo sorter (Beckman-Coulter, Brea, CA, USA). Cells were not cultured in the period between isolation and sorting.
+ Open protocol
+ Expand
4

Identification of SARS-CoV-2 Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from 2 SARS-CoV-2 convalescent donors were expanded with LLL and M1 aAPCs for 14 days; stained with CD3, CD8, L/D, and LLL and M1 tetramers; and sorted on a MoFlo sorter (Beckman Coulter) Three fractions were collected: (a) double staining with LLL+ and M1+ tetramer; (b) LLL+ tetramer only; and (c) M1+ tetramer only.
+ Open protocol
+ Expand
5

Generating shRNA Targeting Canine Hepsin and Prostasin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sfold (http://sfold.wadsworth.org/cgi-bin/index.pl) and siDESIGN center (http://www.thermoscientificbio.com/design-center/) were used to identify siRNAs targeting canine hepsin and prostasin. Selected oligos (sense sequence) are listed in Table 2. Oligonucleotides for shRNA strategy were designed combining the siRNA sequence (sense) followed by a loop (sequence 5’-3’: TTCAAGAGA), the reverse complement of the siRNA sequence (antisense) and RNA polymerase III terminator (sequence 5’-3’: TTTTTTGGAA). Oligos were phosphorylated, annealed and inserted in pENTR/pTER+, a gift from Eric Campeau (plasmid # 17453, Addgene, Cambridge, MA) (Campeau et al., 2009 (link)). MDCK cells stably expressing uromodulin were co-transfected with pENTR/pTER+ vector and EGFP-expressing vector pcDNA3x(+)MyEGFP (Life Technologies). Cells were collected 24 hr after transfection and sorted using MoFlo sorter (Beckman Coulter, Brea, CA). Recovered EGFP-positive cells were maintained in culture for 48 hr.10.7554/eLife.08887.027

Oligonucleotide sequences used to generate shRNAs.

DOI:http://dx.doi.org/10.7554/eLife.08887.027

Target geneTarget position from ATG codonsiRNA oligo (5’-3’)
HPN_siRNA#1122-140CCTTCCTACTCAAGAGTGA
HPN_siRNA#21195-1213TGGATCTTCCAGGCCATAA
PRSS8_siRNA#1258-276GAAGGAAGACTATGAGGTA
PRSS8_siRNA#2593-611TGTACAACATCAACGCTAA
Control siRNANATAGTGAGATTCGTTAAGAT
+ Open protocol
+ Expand
6

Isolation and Osteoclastogenesis of Murine Myeloid Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain lineage-negative CD11b+ and CD11b- cells, WBM cells were red cell-lysed, first labeled with biotin-conjugated lineage antibodies and then incubated with anti-biotin magnetic microbeads to deplete lineage cells. Anti-CD11b microbeads was subsequently used to separate CD11b+ from CD11b- cells. These MACS-purified cells were subjected to osteoclastogenesis assay as routinely done for WBMs or bone marrow macrophages, except they were seeded at a much lower series of density to obtain the optimal number of multinucleated osteoclast formation. MDSC isolation kit was used to obtain bone marrow cells that immuno-phenotypically resembled MDSCs.
For isolation of LSK HSCs, CMPs and GMPs, WBM cells were labeled with FACS antibodies as described above for progenitor analysis and sorted by either Sony Synergy (Sony Biotechnology, San Jose, CA, USA) or MoFlo sorter (Beckman Coulter, Indianapolis, IN, USA). These progenitor cells were sorted into ice-old culture alpha MEM supplemented with 20% FBS to maximize their survival rate. After sorting, cell counts were determined after resuspending cell pellets in a small volume of culture media before plating on 96-well microplates for osteoclastogenesis assay.
+ Open protocol
+ Expand
7

Single-cell RNA Extraction Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 6 h p.i., cells were harvested, washed, stained with Propidium Iodide (Biolegend) and resuspended in FACS buffer containing PBS, 0.3% (v/v) bovine serum albumin (BSA, Sigma) and 2 mM EDTA (Invitrogen). Samples were immediately acquired on a MoFlo sorter (Beckman Coulter) applying fluorescence minus one control to adjust compensation and sorting gates. The accuracy of a high purity single-cell sorting was confirmed using beads and cells. In total, 20,000 live single cells were sorted into Eppendorfs containing 10 µL of PBS supplemented with 40 U/µL of RiboLock RNase inhibitor (ThermoFisher), spun down, and immediately processed for RNA extraction.
+ Open protocol
+ Expand
8

Flow cytometric analysis of CD1 expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD1 expression was determined using mAbs anti–CD1a-PE (clone HI149; BD), anti–CD1b-PE (clone 0249; Santa Cruz Biotechnology, Inc.), anti–CD1c-PE (clone L161; Santa Cruz Biotechnology, Inc.), and anti–CD1d-PE (clone 42.1; BD). Leukemia blasts were identified using anti–CD19-FITC or CD19-PerCPCy5.5 (both clone HIB19) and anti–CD14-FITC (clone HCD14; all from BioLegend); anti–CD3-FITC (clone UCHT1), anti–CD45-APC (clone HI30), and anti–CD117-PerCpCy5.5 (clone 2B8; all from BD); anti–CD7-PC5 (clone 8H8.1), anti–CD10-PC5 (clone ALB1), anti–CD33-FITC or CD33-PC5 or anti–CD33-APC (all clone D3HL60-251), anti–CD34-FITC or CD34-PC5 or anti–CD34-APC (all clone 581), and anti–CD45-PC7 (clone J33; all from Beckman Coulter). cDCs were sorted using anti-CD64 FITC (clone 22; Beckman Coulter) and anti–CD11c-APC (clone B-ly6; BD). Samples were acquired on CyAn ADP (Dako) or FACSCanto (BD) flow cytometers. Cell sorting experiments were performed using a MoFlo sorter (Beckman Coulter). Dead cells were excluded on the basis of propidium iodide and DAPI staining. All data were analyzed using FlowJo software (Tree Star). Relative fluorescent intensity (RFI) of CD1c expression on leukemia cells was calculated dividing the mean CD1c fluorescence intensity by the mean fluorescence intensity of the corresponding isotype control mAb.
+ Open protocol
+ Expand
9

Western Blot Analysis of Tsc1-T-KO CD4 T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed as previously described (26 (link)). Briefly, WT and Tsc1-T-KO CD4 T cells were sorted from splenocytes with a Moflo sorter (Beckman Coulter). Cell lysates of 1 x106 cells in 1% Nonidet P‐40 Lysis solution (1% Nonidet‐40, 150 mM NaCl, and 50 mM Tris, pH 7.4) with freshly added protease and phosphatase inhibitors were subjected to immunoblotting analysis with indicated antibodies. Anti-Tsc1 (D43E2, #6935), anti-phospho-S6 S235/236 (2F9, #4856), anti-phospho-4E-BP1 T37/46 (236B4, # 2855), anti-4E-BP1 (53H11, #9644), and anti-Akt1 (C73H10, #2938) antibodies were purchased from Cell Signaling Technology.
+ Open protocol
+ Expand
10

Flow Cytometry Staining and Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed twice in PBS with 2% BSA and stained with primary antibody for 45 minutes at 4°C in the dark. Cells were then washed and centrifuged twice at 500g and incubated with secondary antibody for an additional 30 minutes. After an additional centrifugation cells were stored on ice until fluorescence activated cell sorting (FACS) analysis, which was performed on a Becton Dickinson LSR Fortessa. Data were analyzed using FlowJo version 8.8.6 (Treestar Inc). DAPI staining and FSC-A and SSC-A gating were used to exclude dead cells and FSC-W and SSC-W gating was applied to exclude doublets. When needed, cell sorting was performed on a Beckman Coulter MoFlo sorter.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!